CLINICAL_TRIALS
trial_result
· 2025-09-03
Clinical Trial Update: Clinical Study of 68Ga-LNC1007 Injection PET/CT [Phase 1]
Summary
Phase 1 clinical study of 68Ga-LNC1007 injection for PET/CT has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yantai LNC Biotechnology Singapore PTE. LTD. | Conditions: Healthy Volunteers, Cancer Patients | Phase 1 | Status: COMPLETED